PremiumRatingsHealthStream: Hold Rating Amid Mixed Financial Performance and Near-Term Challenges HealthStream’s Hold Rating: Balancing Revenue Growth with Cautious Outlook HealthStream’s Promising Growth and Stable Financial Performance Justify Buy Rating PremiumThe FlyHealthStream price target raised to $29 from $28 at Canaccord HealthStream price target raised to $34 from $32 at Barclays Closing Bell Movers: Medpace down 11% after cutting FY24 revenue guide PremiumThe FlyHealthStream price target raised to $28 from $27 at Canaccord HealthStream Announces Q2 Results and Declares Dividend HealthStream backs FY24 revenue view $292M-$296M, consensus $293.98M